Edotreotide, CAS [[204318-14-9]]

Produktübersicht

• Artikelname: Edotreotide, CAS [[204318-14-9]]
• Artikelnummer: MCE-HY-106033
• Hersteller Artikelnummer: HY-106033
• Alternativnummer: MCE-HY-106033-25MG,MCE-HY-106033-5MG,MCE-HY-106033-100MG,MCE-HY-106033-1MG,MCE-HY-106033-50MG,MCE-HY-106033-10MG
• Hersteller: MedchemExpress
• Kategorie: Proteine/Peptide
• Alternative Synonym: DOTATOC, SDZ-SMT 487, SMT 487

Produktbeschreibung

Edotreotide is a ligand that selectively targets SSTR2 and can competitively bind to the receptor. Edotreotide mediates the targeted delivery, while modificated with radionuclides (such as 90Y, 177Lu, and 68Ga) to SSTR-positive tumors and induces tumor cell apoptosis by releasing beta rays. Edotreotide has strong tumor targeting and precise killing activity. Edotreotide is used in the synthesis of radionuclide-drug conjugates (RDCs) and is widely used in the field of neuroendocrine tumors (such as metastatic carcinoids, lung and thymus NETs)[1][2][3].

Produkteigenschaften

• Molekulargewicht: 1421.64
• Reinheit: 98.15
• CAS Nummer: [204318-14-9]
• Formel: C65H92N14O18S2
• Target-Kategorie: Radionuclide-Drug Conjugates (RDCs)

Anwendungsbeschreibung

• Anwendungsbeschreibung: Peptides